Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-93.00	3.25	46.45
Graham Fair Price	615.66	10.11	1.41
PEG	-95.83	< 0.005	0.19
Price/Book	-75.36	0.39	1.59
Price/Cash Flow	-28.28	51.55	-71.88
Prices/Earnings	-91.97	9.03	112.46
Price/Sales	-72.65	2.59	9.48
Price/FCF	-28.28	51.55	-71.88
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-2.23	0.75	0.76
Operating Margin	92.43	0.16	0.08
ROA	214.46	< 0.005	< 0.005
ROE	< 0.005	0.01	206.70
ROIC	< 0.005	< 0.005	258.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.66	0.77	-53.58
EPS QOQ	6.00	11.57	92.86
FCF QOQ	-2.37	1.35	-43.00
Revenue QOQ	0.18	-0.08	-55.74
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	38.83	100.00
Days Sales Outstanding (DSO)	0.00	97.86	100.00
Inventory Turnover	0.00	2.32	100.00
Debt/Capitalization	0.27	0.19	-30.72
Quick Ratio	0.76	0.98	28.44
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	5.01	20.47	308.65
Cash	1.32	5.50	315.88
Capex	< 0.005	-0.04	-706.43
Free Cash Flow	-0.11	0.16	40.39
Revenue	0.84	3.09	268.19
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.40	1.10	-21.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.17	-6.97	24.05
Naive Interpretation	Member

06 - Financial Health · Bad

Rating